Konstantinos Gerasimidis
Overview
Explore the profile of Konstantinos Gerasimidis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
128
Citations
1930
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Huysentruyt K, Hulst J, Gerasimidis K, Joosten K
Curr Opin Clin Nutr Metab Care
. 2025 Feb;
PMID: 39964737
Purpose Of Review: Disease associated malnutrition (DAM) remains an important concern in the care of hospitalized children and children with a chronic disease. This review focused on pediatric literature published...
3.
Atia O, Shavit-Brunschwig Z, Lev-Tzion R, Stein R, Broide E, Urlep D, et al.
Lancet Gastroenterol Hepatol
. 2025 Jan;
10(3):234-247.
PMID: 39788134
Background: Infliximab and adalimumab are the only biologics thus far approved for paediatric patients with inflammatory bowel disease (IBD), so other biologics, such as vedolizumab, are prescribed off-label. Despite its...
4.
Jain V, Dalby M, Alexander E, Burford C, Acford-Palmer H, Serghiou I, et al.
Hepatol Commun
. 2025 Jan;
8(11.
PMID: 39761011
Background: The Kasai portoenterostomy (KPE) aims to re-establish bile flow in biliary atresia (BA); however, BA remains the commonest indication for liver transplantation in pediatrics. Gut microbiota-host interplay is increasingly...
5.
Jatkowska A, White B, Gkikas K, Seenan J, MacDonald J, Gerasimidis K
J Crohns Colitis
. 2024 Nov;
PMID: 39565924
Background: Exclusive enteral nutrition is an established treatment for active Crohn's disease (CD) but the role of partial enteral nutrition (PEN) in the broader management of the disease is less...
6.
Nichols B, Russell R, Short B, Papadopoulou R, Focht G, Ijaz U, et al.
Inflamm Bowel Dis
. 2024 Oct;
PMID: 39419819
Introduction: We investigated relationships between disease activity measures and the gut microbiome in children with Crohn's disease (CD) and how these were confounded by gastrointestinal transit time. Methods: Microbiome was...
7.
Bibi S, Kerbiriou C, Uzma , Mckirdy S, Kostrytsia A, Rasheed H, et al.
Ecotoxicol Environ Saf
. 2024 Sep;
284:116959.
PMID: 39232295
Background: Endemic fluorosis refers to the condition when individuals are exposed to excessive amounts of fluoride ion due to living in a region characterized by elevated levels of fluorine in...
8.
Kerbiriou C, Dickson C, Nichols B, Logan M, Mascellani A, Havlik J, et al.
Inflamm Bowel Dis
. 2024 Jul;
30(12):2457-2466.
PMID: 38982655
Background: Exclusive enteral nutrition (EEN) is an effective treatment for active Crohn's disease (CD). This study explored the immunostimulatory potential of a cell-free fecal filtrate and related this with changes...
9.
Koci O, Russell R, Shaikh M, Edwards C, Gerasimidis K, Zeeshan Ijaz U
Microbiome
. 2024 Jul;
12(1):117.
PMID: 38951915
Background: Shotgun metagenomics for microbial community survey recovers enormous amount of information for microbial genomes that include their abundances, taxonomic, and phylogenetic information, as well as their genomic makeup, the...
10.
White B, Svolos V, Gervais L, Jatkowska A, Nichols B, MacDonald J, et al.
Inflamm Bowel Dis
. 2024 Jun;
31(3):733-745.
PMID: 38920313
Background: The immunological effects of treatment with exclusive enteral nutrition (EEN) in Crohn's disease (CD) remain unknown. We characterized the plasma levels of inflammation-related proteins (IRPs) in children with CD...